Advertisement

Topics

Schering Aktiengesellschaft Company Profile

04:59 EST 15th December 2018 | BioPortfolio

As a successful pharmaceutical company, we are investing in the future of medicine. We develop drugs of high medical value so as to continuously improve the quality of life.
We make the most of knowledge. Using interdisciplinary networks we build bridges to academic researchers around the world, as well as to highly specialized biotech pioneers and partners in the pharmaceutical industry. We combine our own longstanding medical and pharmaceutical expertise with the latest discoveries from genomic research. Throughout, our research focuses on a meaningful combination of early diagnosis, prevention, treatment and therapy control.

We focus on our chosen fields of expertise:

Gynecology & Andrology
Oncology
Diagnostic Imaging
Specialized Therapeutics
As a global player with over 140 subsidiaries we are in close contact with our customers around the world.

Location

Müllerstr. 178
Berlin
13353
Germany

Contact

Phone: 49 30 468 11 11
Fax: 49 30 468 15 305


News Articles [17 Associated News Articles listed on BioPortfolio]

Bayer Schering Pharma: Michael Yeomans on Growth in Pharma and New Deals

In this episode of PharmaTelevision News Review, Fintan Walton talks with Michael Yeomans, VP Business Development & Licensing at Bayer Schering Pharma*. Filmed at BioChicago 2010 in Chicago, USA, the...

TerraGen, Schering-Plough Collaboration to Focus on Discovery of Anti-Infectives

TerraGen Discovery Inc. (Vancouver, BC, Canada) and Schering-Plough Research Institute (SPRI; Kenilworth, NJ) have established a second collaboration to discover novel anti-infective compounds...

DGAP-Adhoc: Bayer Aktiengesellschaft: Bayer will Life-Science-Kerngeschäfte weiter stärken sowie Produktivität und Ertragskraft deutlich steigern (deutsch)

Bayer Aktiengesellschaft: Bayer will Life-Science-Kerngeschäfte weiter stärken sowie Produktivität und Ertragskraft deutlich steigern DGAP-Ad-hoc: Bayer Aktiengesellschaft / Schlagwort(e): Strategi...

STADA Arzneimittel Aktiengesellschaft: Widerruf der Zulassung (General Standard)

STADA Arzneimittel Aktiengesellschaft, Bad Vilbel Widerruf der Zulassung zum regulierten Markt (General Standard) Auf Antrag der Gesellschaft wird die Zulassung der auf den Namen lautenden Stammakt...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bayer Aktiengesellschaft - BAYRY

NEW YORK, Aug. 20, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bayer Aktiengesellschaft ("Bayer" or the "Company") (OTCMKTS: BAYRY). Such investors are adv...

Merck & Co.: Merging With Schering-Plough and Future Plans

In this episode of PharmaTelevision News Review, Fintan Walton talks with Pamela Demain, Executive Director, Corporate Licensing at Merck & Co. Filmed at Bio-Europe Spring 2010 in Barcelona, Spain, th...

Beiersdorf Aktiengesellschaft: Supervisory Board appoints Stefan De Loecker as Chairman of the Executive Board of Beiersdorf

Beiersdorf Aktiengesellschaft / Key word(s): Change of Personnel Beiersdorf Aktiengesellschaft: Supervisory Board appoints Stefan De Loecker as Chairman of the Executive Board of Beiersdorf 15-...

Beiersdorf Aktiengesellschaft: Changes on the Executive Board

Beiersdorf Aktiengesellschaft / Key word(s): Change of Personnel Beiersdorf Aktiengesellschaft: Changes on the Executive Board 21-Jun-2018 / 11:54 CET/CEST Disclosure of an inside information ...

PubMed Articles [0 Results]

None

Clinical Trials [13 Associated Clinical Trials listed on BioPortfolio]

Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis

The primary objective of this study is to evaluate the clinical efficacy of the drug Cloratadd D ® (loratadine + pseudoephedrine sulfate - EMS S/A) compared to the drug Claritin D ® (lor...

Bioequivalence Study of 120 mg Etoricoxib Film-coated Tablets

The present study was a randomized, open-label, two-period, two-sequence, cross-over study, conducted to find out whether the etoricoxib 120 mg film-coated tablet produced by PT Dexa Medic...

Remicade Infusion Management Program (Study P04466)

Schering Canada plans to collect data on about 3000 to 5000 infliximab infusions per year, starting in the third quarter of 2005. It is expected that about 12 sites from the Remicade Infu...

Bioequivalence Study on Loratadine Orally Disintegrating Tablets 10 mg Under Fasting Conditions

To compare the single-dose oral bioavailability of loratadine 10 mg orally disintegrating tablets of Ohm Laboratories (a subsidiary of Ranbaxy Pharmaceuticals Inc., USA) with Claritin® Re...

Bioequivalence Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fed Conditions

The objective of this study was to compare the single-dose relative bioavailability of Ranbaxy and Schering (Claritin-D® 24 hour) 10 mg Loratadine/240 mg Pseudoephedrine Sulfate Extended-...

Companies [46 Associated Companies listed on BioPortfolio]

Schering Health Care Limited

Schering Health Care is the UK subsidiary of Schering AG, an international pharmaceutical company with headquarters located in Berlin, Germany.Schering is a global company, with over 150 subsidiaries ...

Schering-Plough Corp.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies th...

Intervet/Schering-Plough Animal Health

Intervet/Schering-Plough Animal Health, based in Boxmeer, the Netherlands, is focused on the research, development, manufacturing and marketing of animal health products. The company offers customers ...

Schering Aktiengesellschaft

As a successful pharmaceutical company, we are investing in the future of medicine. We develop drugs of high medical value so as to continuously improve the quality of life.We make the most of knowled...

B-R-A-H-M-S Aktiengesellschaft

More Information about "Schering Aktiengesellschaft" on BioPortfolio

We have published hundreds of Schering Aktiengesellschaft news stories on BioPortfolio along with dozens of Schering Aktiengesellschaft Clinical Trials and PubMed Articles about Schering Aktiengesellschaft for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Schering Aktiengesellschaft Companies in our database. You can also find out about relevant Schering Aktiengesellschaft Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record